GC Biopharma wins contract to build blood products plant in Indonesia
The company has received approval from the Indonesian gov't for the construction and technology transfer of blood products plant
By Jun 02, 2023 (Gmt+09:00)
S.Korea's LS Materials set to boost earnings ahead of IPO process
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
Galaxy Ring, new foldables set to steal the show at Samsung Unpacked Paris
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
POSCO gears up for carbon-free steelmaking with hydrogen
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
SK Inc. in talks to sell Pharmteco’s US CDMO plant to Novo Nordisk
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
South Korea sets sights on fostering EDA tech to win HBM chip war
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
![GC Biopharma's headquarters](https://www.kedglobal.com/data/ked/image/2023/06/02/ked202306020004.700x.0.jpg)
GC Biopharma Corp., a South Korean pharmaceutical company, announced on Thursday that it has received approval from the Indonesian Ministry of Health for the construction and technology transfer of a blood products plant.
The Indonesian government has been undertaking the selection process for business rights in order to produce blood products domestically, reducing dependency on imports.
GC Biopharma was selected as the preferred negotiator in January and has since gone through detailed discussions and coordination before officially winning the approval. The specific contract size and details will be disclosed after the contract is finalized.
"This achievement is significant as it reflects the collaboration between our government and private enterprises, resulting in the successful bid for the business rights from a foreign government in the biopharmaceutical industry," said a company official.
GC Biopharma has been producing various blood products since the 1970s, starting with albumin. It has exported blood product plants to Thailand and has experience building factories in countries such as China and Canada.
Write to Ji-Hyun Lee at bluesky@hankyung.com
-
Bio & PharmaGC Biopharma wins $44 mn flu vaccine order from WHO agency
Mar 21, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaGC Biopharma's licensed flu vaccine gets approval in Taiwan
Mar 13, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaGC Biopharma to develop mRNA flu vaccine with Canadian pharma
Mar 09, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaGC Biopharma introduces candidates for treating blood coagulation disease
Mar 02, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaGC Biopharma gets WHO pre-qualification approval for chickenpox vaccine
Feb 21, 2023 (Gmt+09:00)
2 Min read